Controlled Release of Caffeic Acid and Pinocembrin by Use of nPSi-beta CD Composites Improves Their Antiangiogenic Activity
Controlled Release of Caffeic Acid and Pinocembrin by Use of nPSi-beta CD Composites Improves Their Antiangiogenic Activity
Authors
Guzman Oyarzo, Dina
Hernandez Montelongo, Jacobo
Rosas, Carlos
Leal, Pamela
Weber, Helga
Alvear, Marysol
Salazar, Luis A.
Hernandez Montelongo, Jacobo
Rosas, Carlos
Leal, Pamela
Weber, Helga
Alvear, Marysol
Salazar, Luis A.
Profesor GuĆa
Authors
Date
Datos de publicaciĆ³n:
10.3390/pharmaceutics14030484
PHARMACEUTICS,Vol.14,,2022
PHARMACEUTICS,Vol.14,,2022
Tipo de recurso
Article
Keywords
Materia geogrƔfica
Collections
Abstract
Although polyphenols have great pharmacological potential, the main disadvantage is that they have low bioavailability at the desired site. Thus, the use of biocompatible systems for drug delivery is a strategy that is currently gaining great interest. The objective of this study is to evaluate the effect of microencapsulation of caffeic acid and pinocembrin on the antioxidant and antiangiogenic activity of both polyphenols, by the use of nPSi-beta CD composite microparticles. For this HUVEC, cells were exposed to H2O2 and to treatments with polyphenols in solution and loaded in the composite microparticle. The polyphenols were incorporated into a microparticle using nanoporous silicon, chitosan and a beta-cyclodextrin polymer as the biomaterial. The evaluation of the antiangiogenic effect of the treatments with polyphenols in solution and microencapsulated was carried out through functional tests, and the changes in the expression of target genes associated with the antioxidant pathway and angiogenesis was performed through qPCR. The results obtained show that the caffeic acid and pinocembrin have an antioxidant and antiangiogenic activity, both in solution as microencapsulated. In the caffeic acid, a greater biological effect was observed when it was incorporated into the nPSi-beta CD composite microparticle. Our results suggest that the nPSi-beta CD composite microparticle could be used as an alternative oral drug administration system.